Determined by the subgroup Evaluation, we found that there was substantial heterogeneity concerning mortality, favorable results, and the entire therapy effective rate. With regards to mortality, The key reason why for heterogeneity to the subgroup of edaravone dexborneol and EDV was mainly attributed to discrepancies in drug dosage. Regarding favorable https://buyneuroprotectivesonline81233.thezenweb.com/little-known-facts-about-what-are-the-best-neuroprotective-drugs-71291456